Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Neuroendocrine Carcinoma of the Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06939036
What this trial is testing

Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )

Who this might be right for
Small Cell Lung Cancer Extensive StageMerkel Cell Carcinoma
Ariceum Therapeutics GmbH 2
Early research (Phase 1)Study completedNCT00629200
What this trial is testing

Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies

Who this might be right for
Advanced CancerSolid Tumors
M.D. Anderson Cancer Center 33
Early research (Phase 1)Study completedNCT03590054
What this trial is testing

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Stage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more
Rahul Aggarwal 35
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Testing effectiveness (Phase 2)Looking for participantsNCT06151236
What this trial is testing

Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
Melanoma Institute Australia 20
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Early research (Phase 1)Active Not RecruitingNCT04606472
What this trial is testing

SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT02783300
What this trial is testing

An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma

Who this might be right for
Neoplasms
GlaxoSmithKline 297
Testing effectiveness (Phase 2)Looking for participantsNCT07718243
What this trial is testing

Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC

Who this might be right for
Melanoma (Skin Cancer)Non Small Cell Lung CancerSolid Tumor in Advanced Stage
Institute of Cancer Research, United Kingdom 62
Testing effectiveness (Phase 2)Looking for participantsNCT07115043
What this trial is testing

Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more
AstraZeneca 120
Early research (Phase 1)Looking for participantsNCT06021626
What this trial is testing

CRD3874-SI in People With Solid Tumors

Who this might be right for
SarcomaMerkel Cell Carcinoma
Memorial Sloan Kettering Cancer Center 81
Early research (Phase 1)Study completedNCT01652547
What this trial is testing

A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma

Who this might be right for
Metastatic Melanoma and Merkel Cell Carcinoma
Novartis Pharmaceuticals 10
Early research (Phase 1)Ended earlyNCT04551885
What this trial is testing

FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 12
Early research (Phase 1)Study completedNCT00625456
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

Who this might be right for
MelanomaLung CancerRenal Cell Carcinoma+1 more
Jennerex Biotherapeutics 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013
What this trial is testing

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Who this might be right for
Bladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more
Cancer Research UK 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472322
What this trial is testing

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

Who this might be right for
Merkel Cell CarcinomaMerkel Cell Carcinoma, Stage IIIMerkel Cell Carcinoma, Stage IV
University of Wisconsin, Madison 31
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT06596915
What this trial is testing

Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerPancreatic AdenocarcinomaBreast Cancer+1 more
Shandong Boan Biotechnology Co., Ltd 167
Early research (Phase 1)Looking for participantsNCT04913285
What this trial is testing

Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultNon-small Cell Lung CancerMelanoma
Pierre Fabre Medicament 400
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Next Page